Cargando…
A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366830/ https://www.ncbi.nlm.nih.gov/pubmed/30774767 http://dx.doi.org/10.18632/oncotarget.26591 |
| _version_ | 1783393673368567808 |
|---|---|
| author | Nucera, Carmelo |
| author_facet | Nucera, Carmelo |
| author_sort | Nucera, Carmelo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6366830 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63668302019-02-15 A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer Nucera, Carmelo Oncotarget News Impact Journals LLC 2019-01-22 /pmc/articles/PMC6366830/ /pubmed/30774767 http://dx.doi.org/10.18632/oncotarget.26591 Text en Copyright: © 2019 Nucera. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | News Nucera, Carmelo A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer |
| title | A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer |
| title_full | A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer |
| title_fullStr | A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer |
| title_full_unstemmed | A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer |
| title_short | A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer |
| title_sort | novel combined targeted therapy with bromodomain antagonist and mek inhibitor in anaplastic thyroid cancer |
| topic | News |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366830/ https://www.ncbi.nlm.nih.gov/pubmed/30774767 http://dx.doi.org/10.18632/oncotarget.26591 |
| work_keys_str_mv | AT nuceracarmelo anovelcombinedtargetedtherapywithbromodomainantagonistandmekinhibitorinanaplasticthyroidcancer AT nuceracarmelo novelcombinedtargetedtherapywithbromodomainantagonistandmekinhibitorinanaplasticthyroidcancer |